InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: Protector post# 197196

Tuesday, 11/18/2014 12:35:34 PM

Tuesday, November 18, 2014 12:35:34 PM

Post# of 345969

This is good for us, the retail shareholder because just like the PPHM BoD, the employees, the scientists and consultants (Brekken, Garnick,...) that hold PPHM shares, we also want the highest price and not a breadcrumb-grade price because the 'break-in party' has an undisclosed - will be most often seemingly unrelated and unknown - conflict of interest and breaks the BoD majority vote through newly planted members.



I agree 100%

This makes me more suspicious in the way Big Pharma works in how they try to place BOD in place "for exchange of monies" to any small biotech they may want to take over in the future and take over and make an offer for much less than what shareholders deserve.

So what does this say for most of the small biotechs out there that accept monies from Big Pharma or Big Pharma affiliated hedge funds/banks...etc "AND" forced to accept their BOD in exchange for money? It tells me its all part of the plan for most Big Pharma.... after a few rounds of money and a few rounds of adding multiple BOD's.... then the stage is set to make a cheap offer and they have their BOD votes to sell the company and screw over all the retail shareholders that have been true, long term shareholders.

Now it makes more sense why some target the BOD's.... because they will not vote for a cheap single digit Billion $$$ buyout.

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News